(MENAFN- ACCESSWIRE) NEW YORK, NY / ACCESS Newswire / June 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Regencell Bioscience Holdings Limited ("Regencell Bioscience Holdings Limited") (NASDAQ:RGC) concerning possible violations of federal securities laws.

On June 17, 2025, Regencell announced it effected its 38-for-one forward stock split announced earlier this month.

Following this news on June 18, 2025, Regencell's stock price fell by $14.65 per share, or approximately 19% to close at $63.35.

RGC's stock price continued to fall on June 20, 2025 by another $25.34 per share, or approximately 40% to close at $38.01 per share, and fell another 21% to open at $30.00 per share on June 23, 2025.
To obtain additional information, go to:

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500 .

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171

MENAFN25062025004220003708ID1109722002